Published in Fundam Clin Pharmacol on January 01, 1996
Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. Arch Pharm Res (2008) 0.87
Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric artery organ culture model. Br J Pharmacol (2001) 0.85
Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats. Basic Clin Pharmacol Toxicol (2010) 0.81
NS-398 reverses hypotension in endotoxemic rats: contribution of eicosanoids, NO, and peroxynitrite. Prostaglandins Other Lipid Mediat (2012) 0.79
Piroxicam reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. Basic Clin Pharmacol Toxicol (2011) 0.78
Resveratrol enhances vascular reactivity in mice following lipopolysaccharide challenge via the RhoA-ROCK-MLCP pathway. Exp Ther Med (2017) 0.75
Coronary artery ligation in anesthetized rats as a method for the production of experimental dysrhythmias and for the determination of infarct size. J Pharmacol Methods (1980) 3.10
Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol (1990) 2.83
Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J (1999) 2.75
Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines. Br J Pharmacol (1973) 2.62
Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res (1990) 2.51
The effect of hypercapnia on myocardial blood flow and metabolism. J Physiol (1970) 2.26
Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology (2006) 2.24
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA (1998) 2.20
Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem Pharmacol (1986) 2.04
Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts. Br J Pharmacol (1972) 1.94
Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation. Br J Pharmacol (1975) 1.91
Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res (1992) 1.86
Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J Infect Dis (1980) 1.82
Changes in blood flow and oxygen consumption in normal and ischaemic regions of the myocardium following acute coronary artery ligation. Cardiovasc Res (1974) 1.77
The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat. Br J Pharmacol (1974) 1.63
Spatial distributions of expansion rate, cell division rate and cell size in maize leaves: a synthesis of the effects of soil water status, evaporative demand and temperature. J Exp Bot (2000) 1.58
The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanism. Cardiovasc Res (1993) 1.57
Vasospastic elements in myocardial infarction following coronary occlusion in the dog. Cardiovasc Res (1968) 1.55
Myocardial vascular reactivity after beta-adrenergic blockade. Lancet (1966) 1.55
Haemodynamic and myocardial effects of hyperbaric oxygen in dogs subjected to haemorrhage. Cardiovasc Res (1971) 1.54
Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol (1982) 1.53
Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature (1981) 1.53
Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun (1990) 1.53
Petrified ears. Clin Exp Dermatol (1997) 1.48
A species comparison of the effects of changing perfusion pressure on blood flow and metabolic heat production in the myocardium. J Physiol (1966) 1.46
Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure. Clin Exp Pharmacol Physiol (1975) 1.45
Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol (1997) 1.41
Innovation in orthopaedic surgery as it relates to evidence-based practice. Knee Surg Sports Traumatol Arthrosc (2013) 1.41
The concept of individualized anatomic anterior cruciate ligament (ACL) reconstruction. Knee Surg Sports Traumatol Arthrosc (2013) 1.41
Studies on the mode of action of hexobendine, a prospective anti-anginal drug. Br J Pharmacol (1969) 1.39
An independent pilot study into the accuracy and reliability of home blood glucose monitors. Lancet (1999) 1.39
Proceedings: Inhibitory effect of propranolol on insulin secretion. Br J Pharmacol (1973) 1.39
The effect of "selective" beta-adrenoceptor blocking drugs on the myocardial circulation. Br J Pharmacol (1970) 1.31
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium. Br J Pharmacol (1973) 1.31
The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation. Br J Pharmacol (1969) 1.27
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol (2000) 1.25
The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol (1991) 1.23
A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J (2001) 1.23
Pharmacological aspects of the coronary circulation. Prog Med Chem (1969) 1.23
The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol (1977) 1.23
The hypoglycaemic effect of 5-hydroxytryptophan. Br J Pharmacol (1974) 1.22
Effect of Phloem-Translocated Malate on NO(3) Uptake by Roots of Intact Soybean Plants. Plant Physiol (1992) 1.22
Antiarrhythmic actions of meptazinol, a partial agonist at opiate receptors, in acute myocardial ischaemia. Br J Pharmacol (1983) 1.21
Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol (1991) 1.21
Impairment of glucose tolerance produced by diuretics and other drugs. Pharmacol Ther (1981) 1.21
Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population. Sleep (2009) 1.19
Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension (2001) 1.19
Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr (1998) 1.19
Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol (1991) 1.19
The effects of amyl nitrite inhalation on myocardial blood flow and metabolic heat production. Br J Pharmacol Chemother (1967) 1.17
The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat. Br J Pharmacol (1976) 1.16
Medication of the hypoglycaemic effect of 5-hydroxytryptophan by a central nervous system action. Experientia (1974) 1.15
Suppression by orally-administered nifedipine, nisoldipine and niludipine of early, life-threatening ventricular arrhythmias resulting from acute myocardial ischaemia. Br J Pharmacol (1981) 1.15
The effects of prolonged oral administration of a new antidysrhythmic drug (Org 6001) on coronary artery ligation dysrhythmias in conscious and anesthetized rats. J Cardiovasc Pharmacol (1980) 1.14
The effects of prostaglandins E2, F2 alpha, prostacyclin, flurbiprofen and aspirin on arrhythmias resulting from coronary artery ligation in anaesthetized rats. Br J Pharmacol (1981) 1.13
Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol (1991) 1.13
Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J Physiol (1996) 1.13
Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res (1991) 1.12
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology (2002) 1.12
Adrenergic receptors in the coronary circulation. Am Heart J (1967) 1.12
Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity. Br J Pharmacol (1977) 1.12
Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs. Br J Pharmacol (1981) 1.11
Endothelial mediated inhibition of contraction and increase in cyclic GMP levels evoked by the alpha-adrenoceptor agonist B-HT 920 in rat isolated aorta. Br J Pharmacol (1984) 1.11
Prophylactic lignocaine and early post-coronary artery occlusion dysrhythmias in anaesthetized greyhounds. Br J Pharmacol (1980) 1.10
Enzymes in normally perfused and ischaemic dog hearts which release a substance with kinin like activity. Cardiovasc Res (1989) 1.09
Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res (2008) 1.09
Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol (1991) 1.09
Myocardial and haemodynamic effects of phentolamine. Br J Pharmacol (1971) 1.08
The effect of adrenaline, noradrenaline, and propranolol on myocardial blood flow and metabolic heat production in monkeys and baboons. Cardiovasc Res (1969) 1.07
Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats. Br J Pharmacol (1984) 1.05
Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function. Circulation (2001) 1.05
Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res (2000) 1.05
Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem Pharmacol (1987) 1.05
The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium. Am Heart J (1973) 1.05
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol (1984) 1.04
Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds. J Cardiovasc Pharmacol (1983) 1.04
Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by alpha-adrenoceptor agonists in rat aorta. J Cardiovasc Pharmacol (1991) 1.04
Calcium antagonists prevent early post-infarction ventricular fibrillation. Eur J Pharmacol (1981) 1.04
The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Br J Pharmacol (1970) 1.04
Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol (1994) 1.03
Relationship of HLA to schizophrenia not supported in multiplex families. Psychiatry Res (1992) 1.03
Reduction in ventricular arrhythmias following acute coronary artery ligation in the dog after the administration of creatine phosphate. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.03
The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats. Br J Pharmacol (1983) 1.02
The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent. Br J Pharmacol (1977) 1.02
Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery. Br J Pharmacol (1992) 1.01
Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity. Br J Pharmacol (1995) 1.01
Stereospecific antiarrhythmic effect of opioid receptor antagonists in myocardial ischaemia. Br J Pharmacol (1986) 1.01